Clinical Trial Update: Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the combination of docetaxel and oxaliplatin in patients with stage III or IV ovarian cancer (epithelial).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group | Conditions: Ovarian Cancer | Phase 1, Phase 2 | Status: UNKNOWN